Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2012

01-04-2012 | Original Article

Enhanced Gastric Ghrelin Production and Secretion in Rats with Gastric Outlet Obstruction

Authors: Eisuke Iwasaki, Hidekazu Suzuki, Tatsuhiro Masaoka, Toshihiro Nishizawa, Hiroshi Hosoda, Kenji Kangawa, Toshifumi Hibi

Published in: Digestive Diseases and Sciences | Issue 4/2012

Login to get access

Abstract

Background and Aim

Ghrelin has distinct effects on gastrointestinal motility through the vagus nerve and gastric excitatory neural plexus. The objectives of this study were to investigate the dynamics of ghrelin and expression of neuromuscular markers in a newly established surgically manipulated rat model of gastric outlet obstruction (GOO), akin to the pyloric stricture associated with duodenal ulcer, advanced gastric cancer, and other conditions, in the clinical setting.

Material and Methods

The rats were divided into two groups, a control group (sham operation) and the GOO group (proximal duodenal stricture). The animals were sacrificed 2 weeks after the operation. Plasma and gastric ghrelin were measured by radioimmunoassay. mRNA expression in the stomach of neural choline acetyltransferase (ChAT), c-kit, and membrane-bound stem cell factor (SCF) were analyzed by quantitative RT-PCR. In addition, gastric mRNA expression of the aforementioned were also evaluated 60 min after intraperitoneal administration of a synthetic GHS-R1a antagonist ([d-Lys3] GHRP-6 6.0 mg/kg).

Results

Mechanical GOO induced increases of fasting plasma ghrelin levels and hyperplasia of the gastric muscle layers, with enhanced expression of the gastric neuromuscular markers. Administration of [d-Lys3] GHRP-6 normalized the enhanced expression of c-kit and SCF.

Conclusion

GOO stimulates ghrelin dynamics and then enhances the mechanistic expression of gastric cellular communication network molecules between nerves and smooth muscle cells.
Literature
1.
go back to reference Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–660.PubMedCrossRef Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–660.PubMedCrossRef
2.
go back to reference Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905–908.PubMedCrossRef Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905–908.PubMedCrossRef
3.
go back to reference Xu L, Depoortere I, Tomasetto C, et al. Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus. Regul Pept. 2005;124:119–125.PubMedCrossRef Xu L, Depoortere I, Tomasetto C, et al. Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus. Regul Pept. 2005;124:119–125.PubMedCrossRef
4.
go back to reference De Winter BY, De Man JG, Seerden TC, et al. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil. 2004;16:439–446.PubMedCrossRef De Winter BY, De Man JG, Seerden TC, et al. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil. 2004;16:439–446.PubMedCrossRef
5.
go back to reference Fujino K, Inui A, Asakawa A, et al. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol. 2003;550:227–240.PubMedCrossRef Fujino K, Inui A, Asakawa A, et al. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol. 2003;550:227–240.PubMedCrossRef
6.
go back to reference Chasen M, Bhargava R. Gastrointestinal symptoms, electrogastrography, inflammatory markers, and pg-sga in patients with advanced cancer. Support Care Cancer. 2011 [Epub ahead of print]. Chasen M, Bhargava R. Gastrointestinal symptoms, electrogastrography, inflammatory markers, and pg-sga in patients with advanced cancer. Support Care Cancer. 2011 [Epub ahead of print].
7.
go back to reference Nishizawa T, Suzuki H, Nomoto Y, et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther. 2006;24(Suppl 4):104–110. Nishizawa T, Suzuki H, Nomoto Y, et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther. 2006;24(Suppl 4):104–110.
8.
go back to reference Ohnishi N, Okada K, Yoshioka M, et al. Studies on interactions between traditional herbal and western medicines. V. Effects of sho-saiko-to (xiao-cai-hu-tang) on the pharmacokinetics of carbamazepine in rats. Biol Pharm Bull. 2002;25:1461–1466.PubMedCrossRef Ohnishi N, Okada K, Yoshioka M, et al. Studies on interactions between traditional herbal and western medicines. V. Effects of sho-saiko-to (xiao-cai-hu-tang) on the pharmacokinetics of carbamazepine in rats. Biol Pharm Bull. 2002;25:1461–1466.PubMedCrossRef
9.
go back to reference Ariyasu H, Takaya K, Hosoda H, et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology. 2002;143:3341–3350.PubMedCrossRef Ariyasu H, Takaya K, Hosoda H, et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology. 2002;143:3341–3350.PubMedCrossRef
10.
go back to reference Hosoda H, Kojima M, Matsuo H, et al. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279:909–913.PubMedCrossRef Hosoda H, Kojima M, Matsuo H, et al. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279:909–913.PubMedCrossRef
11.
go back to reference Masaoka T, Suzuki H, Hosoda H, et al. Enhanced plasma ghrelin levels in rats with streptozotocin-induced diabetes. FEBS Lett. 2003;541:64–68.PubMedCrossRef Masaoka T, Suzuki H, Hosoda H, et al. Enhanced plasma ghrelin levels in rats with streptozotocin-induced diabetes. FEBS Lett. 2003;541:64–68.PubMedCrossRef
12.
go back to reference Bisschops R. Ligand and electrically induced activation patterns in myenteric neuronal networks. Confocal calcium imaging as a bridge between basic and human physiology. Verh K Acad Geneeskd Belg. 2008;70:105–145.PubMed Bisschops R. Ligand and electrically induced activation patterns in myenteric neuronal networks. Confocal calcium imaging as a bridge between basic and human physiology. Verh K Acad Geneeskd Belg. 2008;70:105–145.PubMed
13.
go back to reference Sakata I, Yamazaki M, Inoue K, et al. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett. 2003;342:183–186.PubMedCrossRef Sakata I, Yamazaki M, Inoue K, et al. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci Lett. 2003;342:183–186.PubMedCrossRef
14.
go back to reference Suzuki H, Masaoka T, Hosoda H, et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in mongolian gerbils. Gut. 2004;53:187–194.PubMedCrossRef Suzuki H, Masaoka T, Hosoda H, et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in mongolian gerbils. Gut. 2004;53:187–194.PubMedCrossRef
15.
go back to reference Izbeki F, Wittman T, Rosztoczy A, et al. Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract. 2008;80:192–198.PubMedCrossRef Izbeki F, Wittman T, Rosztoczy A, et al. Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract. 2008;80:192–198.PubMedCrossRef
16.
go back to reference Suzuki S, Suzuki H, Horiguchi K, et al. Delayed gastric emptying and disruption of the interstitial cells of cajal network after gastric ischaemia and reperfusion. Neurogastroenterol Motil. 2010;22:585–593, e126. Suzuki S, Suzuki H, Horiguchi K, et al. Delayed gastric emptying and disruption of the interstitial cells of cajal network after gastric ischaemia and reperfusion. Neurogastroenterol Motil. 2010;22:585–593, e126.
17.
go back to reference Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMedCrossRef Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMedCrossRef
Metadata
Title
Enhanced Gastric Ghrelin Production and Secretion in Rats with Gastric Outlet Obstruction
Authors
Eisuke Iwasaki
Hidekazu Suzuki
Tatsuhiro Masaoka
Toshihiro Nishizawa
Hiroshi Hosoda
Kenji Kangawa
Toshifumi Hibi
Publication date
01-04-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1953-y

Other articles of this Issue 4/2012

Digestive Diseases and Sciences 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.